CINCINNATI, Feb. 11, 2022 /PRNewswire/ -- Ms.Medicine, a national healthcare organization whose mission is to improve the quality of healthcare for women, is pleased to announce its newest board ...

MENLO PARK, Calif. and CINCINNATI, Dec. 3, 2025 /PRNewswire/ -- MyOme, a leading clinical whole-genome testing and polygenic risk modelling (PRS) company, today announced a strategic partnership with ...

Liz Engel, Digital editor/Cincy Inno editor - Cincinnati Business Courier Sep 1, 2023, 4:58am MST David Stephen for ACBJ Dr. Lisa Larkin is the CEO and founder of Ms.Medicine and the president and ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

The right multiple sclerosis (MS) treatment can slow your disease and reduce the number of attacks you get. But if you're a woman -- as 3 out of 4 people with MS are -- choosing a treatment becomes ...

A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.

How Does Ocrevus or Ocrevus Zunovo Work in MS? MS happens when your immune system damages the protective covering around the nerves in your brain, called myelin. This affects how your brain ...